These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9623552)

  • 1. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
    Kliem V; Bahlmann J; Hartmann M; Huber R; Lühmann R; Wurst W
    Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S7-16. PubMed ID: 8793599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
    Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S18-24. PubMed ID: 8793600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):481-5. PubMed ID: 8520804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.
    Ferron GM; Preston RA; Noveck RJ; Pockros P; Mayer P; Getsy J; Turner M; Abell M; Paul J
    Clin Ther; 2001 Aug; 23(8):1180-92. PubMed ID: 11558857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole does not interact with the pharmacokinetics of carbamazepine.
    Huber R; Bliesath H; Hartmann M; Steinijans VW; Koch H; Mascher H; Wurst W
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):521-4. PubMed ID: 9799054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):243-62. PubMed ID: 8793611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantoprazole.
    Poole P
    Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):51-5. PubMed ID: 8929746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers.
    Tanaka M; Yamazaki H; Ryokawa Y; Hakusui H; Nakamichi N; Sekino H
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):415-9. PubMed ID: 8897077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration.
    Bliesath H; Huber R; Hartmann M; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):44-50. PubMed ID: 8199751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.